{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:56:34Z","timestamp":1771023394299,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23659748"],"award-info":[{"award-number":["23659748"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24390403"],"award-info":[{"award-number":["24390403"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26670791"],"award-info":[{"award-number":["26670791"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jiac.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T09:54:32Z","timestamp":1454925272000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Masaru","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Hamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9558-9011","authenticated-orcid":false,"given":"Teiji","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.01.006_bib1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S2213-2600(14)70171-7","article-title":"Respiratory infections in patients undergoing mechanical ventilation","volume":"2","author":"Rello","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib2","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10096-012-1629-3","article-title":"Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients","volume":"31","author":"Pena","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2052-0492-2-10","article-title":"The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response","volume":"2","author":"Sawa","year":"2014","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.jiac.2016.01.006_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s13054-014-0668-9","article-title":"Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review","volume":"18","author":"Sawa","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2016.01.006_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2958.1997.4891851.x","article-title":"ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury","volume":"25","author":"Finck-Barban\u00e7on","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jiac.2016.01.006_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1172\/JCI7124","article-title":"Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia","volume":"104","author":"Kurahashi","year":"1999","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.jiac.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/CCM.0000000000001271","article-title":"Intravenous immunoglobulin for acute lung injury and bacteremia in Pseudomonas aeruginosa pneumonia","volume":"44","author":"Katoh","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4161\/21645515.2014.971641","article-title":"Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa","volume":"10","author":"Sawa","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jiac.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12879-014-0650-9","article-title":"Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study","volume":"14","author":"Willmann","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.burns.2004.09.002","article-title":"Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge","volume":"31","author":"Neely","year":"2005","journal-title":"Burns"},{"key":"10.1016\/j.jiac.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/IAI.66.7.3242-3249.1998","article-title":"In\u00a0vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections","volume":"66","author":"Sawa","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.4049\/jimmunol.159.6.2858","article-title":"IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia","volume":"159","author":"Sawa","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2016.01.006_bib15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.36.7.1352","article-title":"Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice","volume":"36","author":"Oishi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.01.006_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.37.2.164","article-title":"Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia","volume":"37","author":"Oishi","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1348-0421.2009.00165.x","article-title":"Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice","volume":"53","author":"Moriyama","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jiac.2016.01.006_bib18","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1086\/320737","article-title":"Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections","volume":"183","author":"Roy-Burman","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00003246-200203000-00005","article-title":"Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"30","author":"Hauser","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1469-0691.2007.01939.x","article-title":"Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa","volume":"14","author":"Wong-Beringer","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/fpd.2010.0687","article-title":"Detection of type III secretion system virulence and mutations in gyrA and parC genes among quinolone-resistant strains of Pseudomonas aeruginosa isolated from imported shrimp","volume":"8","author":"Tran","year":"2011","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"e42973","DOI":"10.1371\/journal.pone.0042973","article-title":"Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa","volume":"7","author":"Agnello","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3343\/alm.2014.34.4.286","article-title":"Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa","volume":"34","author":"Cho","year":"2014","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/CCM.0b013e318298a86f","article-title":"Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa","volume":"42","author":"Sullivan","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/ciu866","article-title":"Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections","volume":"60","author":"Pena","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1093\/emboj\/cdg499","article-title":"Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas","volume":"22","author":"Schoehn","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.jiac.2016.01.006_bib27","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/IAI.71.4.2230-2233.2003","article-title":"Protein binding between PcrG-PcrV and PcrH-PopB\/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system","volume":"71","author":"Allmond","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2016.01.006_bib28","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.167.10.5880","article-title":"Therapeutic administration of anti-PcrV F(ab\u2032)(2) in sepsis associated with Pseudomonas aeruginosa","volume":"167","author":"Shime","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2016.01.006_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/341069","article-title":"Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV","volume":"186","author":"Frank","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-8518-1-2","article-title":"Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model","volume":"1","author":"Faure","year":"2003","journal-title":"J\u00a0Immune Based Ther Vaccines"},{"key":"10.1016\/j.jiac.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1183\/09031936.00147406","article-title":"Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model","volume":"29","author":"Imamura","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10096-011-1509-2","article-title":"PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice","volume":"31","author":"Song","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.resp.2014.01.001","article-title":"PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury","volume":"193","author":"Wang","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.jiac.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/IAI.00815-08","article-title":"An engineered human antibody Fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity","volume":"77","author":"Baer","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2016.01.006_bib35","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/CCM.0b013e31825334f6","article-title":"Safety and pharmacokinetics of an anti-PcrV pegylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized, double-blind, placebo-controlled trial","volume":"40","author":"Francois","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ppul.22890","article-title":"Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection","volume":"49","author":"Milla","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jiac.2016.01.006_bib37","first-page":"159","article-title":"Antibiotic induced endotoxin release and clinical sepsis: a review","volume":"13","author":"Holzheimer","year":"2001","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2016.01.006_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00134-002-1330-6","article-title":"Clinical implications of antibiotic-induced endotoxin release in septic shock","volume":"28","author":"Lepper","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2016.01.006_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clind\/15.5.840","article-title":"Antibiotic-induced release of endotoxin: a reappraisal","volume":"15","author":"Hurley","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0732-8893(93)90109-K","article-title":"Effect of antibiotics on endotoxin release from gram-negative bacteria","volume":"16","author":"Eng","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2016.01.006_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0924-8579(99)00044-8","article-title":"New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock","volume":"12","author":"Periti","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2016.01.006_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","article-title":"Colistin for lung infection: an update","volume":"3","author":"Gurjar","year":"2015","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.jiac.2016.01.006_bib43","article-title":"Colistin: revival of an old polymyxin antibiotic","author":"Dijkmans","year":"2014","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1600026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1600026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:54:35Z","timestamp":1761159275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X1600026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1341321X1600026X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.01.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}